Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
Condition: Carcinoma of Unknown Primary Intervention: Drug: Pembrolizumab Injection Sponsor: AHS Cancer Control Alberta Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials